Astec Lifesciences Ltd

₹ 686 -1.03%

30 Apr - close price

About

The Company is into manufacturing of agrochemical active ingredients (technical), bulk and formulations, intermediate products and it sells its products in India as well as exports them to approximately 24 countries.
Astec also has undertaken a number of custom synthesis projects, for its clients in Europe, Japan and the US. It is present only in business to business sale (B2B).^[1] ^[2] ^[3]

Key Points

Product Portfolio
The company offers a range of products and intermediates, including fungicides, insecticides, herbicides, and various chemical compounds, serving global customers and including triazole fungicides, heterocyclic herbicides, sulfonylurea herbicides, synthetic pyrethroids, fluorinated compounds, halides, intermediates, ketones, ethers, alcohols, and many others. ^[1]

Website BSE NSE

Market Cap ₹ 1,345 Cr.
Current Price ₹ 686
High / Low ₹ 1,488 / 648
Stock P/E
Book Value ₹ 120
Dividend Yield 0.00 %
ROCE -12.6 %
ROE -44.6 %
Face Value ₹ 10.0

Add ratio to table

Edit ratios

Pros

Promoter holding has increased by 4.12% over last quarter.

Cons

Stock is trading at 5.73 times its book value
Company has low interest coverage ratio.
The company has delivered a poor sales growth of -6.11% over past five years.
Company has a low return on equity of -14.1% over last 3 years.
Company might be capitalizing the interest cost

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Agro Chemicals Industry: Pesticides / Agrochemicals - Indian

Part of BSE SmallCap BSE Allcap BSE Commodities

Edit Columns

Loading peers table ...

Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
	272	184	200	117	127	143	111	51	154	69	99	94	120
	207	159	166	105	122	140	114	69	141	116	118	100	114
Operating Profit	65	25	33	12	5	3	-3	-18	13	-46	-20	-6	6
OPM %	24%	14%	17%	10%	4%	2%	-3%	-36%	8%	-67%	-20%	-6%	5%
	7	3	4	4	3	2	1	1	2	1	2	2	1
Interest	3	4	5	6	6	6	6	6	7	7	9	10	10
Depreciation	11	9	8	9	8	9	9	9	9	9	11	11	12
Profit before tax	58	15	25	1	-6	-11	-18	-32	-1	-62	-39	-25	-16
Tax %	26%	25%	25%	31%	-20%	-26%	-24%	-24%	4%	-36%	0%	61%	3%
	43	11	18	1	-5	-8	-13	-24	-1	-40	-39	-40	-16
EPS in Rs	21.97	5.82	9.34	0.43	-2.54	-4.18	-6.85	-12.41	-0.49	-20.25	-19.66	-20.59	-8.20
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
	207	267	233	299	368	431	523	555	677	628	458	381
	171	213	201	236	299	354	437	443	522	551	464	448
Operating Profit	35	54	32	63	69	76	85	112	154	77	-6	-66
OPM %	17%	20%	14%	21%	19%	18%	16%	20%	23%	12%	-1%	-17%
	-0	-16	4	-8	12	11	12	8	10	13	6	6
Interest	9	13	13	12	11	12	13	5	9	21	25	37
Depreciation	15	13	10	14	15	19	23	26	34	34	36	44
Profit before tax	11	13	12	29	56	56	61	89	121	35	-62	-141
Tax %	22%	-17%	59%	33%	37%	36%	23%	27%	26%	27%	-24%	-4%
	9	15	5	19	35	36	48	65	90	26	-47	-135
EPS in Rs	4.68	7.60	2.55	9.80	17.87	18.28	24.28	33.21	45.85	13.04	-23.93	-68.71
Dividend Payout %	21%	16%	0%	15%	8%	8%	6%	5%	3%	12%	-6%	0%

Compounded Sales Growth
10 Years:	4%
5 Years:	-6%
3 Years:	-17%
TTM:	-17%

Compounded Profit Growth
10 Years:	%
5 Years:	%
3 Years:	%
TTM:	-188%

Stock Price CAGR
10 Years:	17%
5 Years:	10%
3 Years:	-29%
1 Year:	-47%

Return on Equity
10 Years:	6%
5 Years:	0%
3 Years:	-14%
Last Year:	-45%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	19	19	19	20	20	20	20	20	20	20	20	20
Reserves	95	116	99	119	150	183	227	290	377	400	350	215
	83	93	127	127	125	176	99	187	279	341	494	555
	88	133	85	69	119	83	226	181	221	219	112	92
Total Liabilities	284	362	330	334	413	461	572	678	897	979	975	881
	132	133	95	103	115	167	194	213	340	318	386	520
CWIP	6	12	20	8	42	19	24	116	23	127	165	0
Investments	0	0	0	0	0	0	0	0	0	0	0	0
	146	216	215	223	256	275	354	349	534	534	424	361
Total Assets	284	362	330	334	413	461	572	678	897	979	975	881

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
	15	7	-13	19	65	15	168	-8	24	75	10	-8
	-19	-19	-17	-18	-49	-52	-74	-73	-104	-113	-135	-15
	3	12	31	-1	-18	37	-95	81	80	38	125	24
Net Cash Flow	-1	-0	2	1	-3	-0	0	0	0	-0	0	0

Ratios

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Debtor Days	91	142	126	135	122	103	112	123	148	90	135	141
Inventory Days	192	147	177	133	122	121	131	113	176	268	224	196
Days Payable	114	179	169	116	155	83	218	137	179	161	102	100
Cash Conversion Cycle	168	109	134	152	89	142	25	100	145	197	256	237
Working Capital Days	125	125	142	154	115	147	77	101	163	175	234	237
ROCE %	11%	20%	12%	20%	22%	20%	20%	22%	22%	8%	-4%	-13%

Shareholding Pattern

Numbers in percentages

	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
	65.29%	66.77%	66.76%	66.76%	66.76%	66.75%	66.75%	66.75%	66.75%	66.74%	66.74%	70.87%
	0.48%	1.53%	2.19%	2.29%	1.95%	1.33%	1.28%	1.25%	1.03%	0.53%	1.20%	0.25%
	11.79%	9.82%	9.57%	10.58%	10.15%	10.16%	9.74%	7.88%	3.37%	4.50%	5.40%	4.34%
	22.45%	21.87%	21.49%	20.37%	21.13%	21.74%	22.22%	24.12%	28.85%	28.20%	26.64%	24.53%
No. of Shareholders	17,433	17,632	19,545	17,809	18,703	18,722	19,244	19,848	19,955	19,727	19,057	18,689

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
	65.54%	67.31%	67.62%	71.33%	65.23%	65.29%	66.76%	66.75%	70.87%
	1.87%	0.77%	0.89%	0.84%	0.25%	0.32%	2.29%	1.25%	0.25%
	0.27%	2.17%	2.10%	0.51%	10.67%	12.56%	10.58%	7.88%	4.34%
	0.00%	0.01%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
	32.32%	29.74%	29.39%	27.32%	23.85%	21.83%	20.37%	24.12%	24.53%
No. of Shareholders	11,907	13,197	12,771	10,701	19,872	16,951	17,809	19,848	18,689

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

All

Annual reports

DRHP

Credit ratings

Concalls

Nov 2022
Transcript
PPT
Nov 2022
Transcript
PPT
May 2022
Transcript
PPT
Nov 2021
Transcript
PPT
Aug 2021
Transcript
PPT
Feb 2021
Transcript
PPT